Archivos de la Sociedad Espanola de Oftalmologia · Nov 2026

Applications of artificial intelligence in the screening, diagnosis, and monitoring of posterior pole diseases

By Martínez-Albert N, Monsálvez-Romín D

Artificial intelligence (AI) has undergone substantial development in ophthalmology, with applications expanding beyond diagnosis to include screening, monitoring, and estimation of disease progression risk. This narrative review synthesizes evidence on machine learning and deep learning algorithms for ocular image analysis. Diabetic retinopathy has the highest level of clinical maturity, with automated screening systems demonstrating high diagnostic performance and receiving regulatory authorization for clinical use. In age-related macular degeneration and glaucoma, AI enables lesion detection, disease classification, integration of structural and functional information, and estimation of progression risk, although many applications require prospective validation to confirm their clinical utility. Promising results have also been reported in pathologic myopia, retinal vascular occlusions, and retinal detachment, although these applications remain at earlier stages of development. However, important limitations remain regarding external validation, generalizability, interpretability, and ethical and regulatory considerations.

doi.org/10.1016/j.oftal.2026.502719Biomarkers

AgingResearch.News